DE69322127T2 - Verfahren zur Herstellung von Peptidderivaten und ihrer Salze - Google Patents

Verfahren zur Herstellung von Peptidderivaten und ihrer Salze

Info

Publication number
DE69322127T2
DE69322127T2 DE1993622127 DE69322127T DE69322127T2 DE 69322127 T2 DE69322127 T2 DE 69322127T2 DE 1993622127 DE1993622127 DE 1993622127 DE 69322127 T DE69322127 T DE 69322127T DE 69322127 T2 DE69322127 T2 DE 69322127T2
Authority
DE
Germany
Prior art keywords
salts
preparation
peptide derivatives
peptide
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE1993622127
Other languages
English (en)
Other versions
DE69322127D1 (de
Inventor
Tsutomu Mimoto
Sumitsugu Kisanuki
Osamu Takahasihi
Yoshiaki Kiso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eneos Corp
Original Assignee
Japan Energy Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP19265492A external-priority patent/JPH06247948A/ja
Priority claimed from JP19265392A external-priority patent/JP2601390B2/ja
Priority claimed from JP4323599A external-priority patent/JPH06192246A/ja
Application filed by Japan Energy Corp filed Critical Japan Energy Corp
Publication of DE69322127D1 publication Critical patent/DE69322127D1/de
Application granted granted Critical
Publication of DE69322127T2 publication Critical patent/DE69322127T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE1993622127 1992-05-13 1993-05-11 Verfahren zur Herstellung von Peptidderivaten und ihrer Salze Expired - Fee Related DE69322127T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP19265492A JPH06247948A (ja) 1992-05-13 1992-05-13 １，３−チアゾリジン−４−カルボン酸誘導体またはその塩の製造方法
JP19265392A JP2601390B2 (ja) 1992-05-13 1992-05-13 ３−アルキルチオ−２−アミノプロピオン酸誘導体またはその塩の製造方法
JP15745992 1992-05-25
JP31564092 1992-10-30
JP4323599A JPH06192246A (ja) 1992-05-25 1992-11-09 ペプチド誘導体またはその塩の製造方法

Publications (2)

Publication Number Publication Date
DE69322127D1 DE69322127D1 (de) 1998-12-24
DE69322127T2 true DE69322127T2 (de) 1999-06-24

Family

ID=27528149

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1993622127 Expired - Fee Related DE69322127T2 (de) 1992-05-13 1993-05-11 Verfahren zur Herstellung von Peptidderivaten und ihrer Salze

Country Status (2)

Country Link
EP (1) EP0574135B1 (de)
DE (1) DE69322127T2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2126794C1 (ru) 1992-03-11 1999-02-27 Нархекс Лимитед Аминопроизводные оксо- или гидроксизамещенных гидразинов, способ их получения и фармацевтические композиции для ингибирования ретровирусной протеазы
US5888992A (en) 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
US6071895A (en) 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
IL110898A0 (en) * 1993-09-10 1994-11-28 Narhex Australia Pty Ltd Polar-substituted hydrocarbons
US6037157A (en) 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
DE60120216T2 (de) 2000-12-11 2007-03-29 Mitsubishi Gas Chemical Co., Inc. Verfahren zur Herstellung von optisch aktiver (4R)-1,3-Thiazolidin-4-Carboxylsäure
HN2002000136A (es) 2001-06-11 2003-07-31 Basf Ag Inhibidores de la proteasa del virus hiv, compuestos que contienen a los mismos, sus usos farmaceuticos y los materiales para su sintesis
US7094909B2 (en) 2001-06-11 2006-08-22 Agouron Pharmaceuticals, Inc. HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
US7169932B2 (en) 2001-06-11 2007-01-30 Pfizer Inc. HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100899A (en) * 1991-02-08 1997-06-10 Sankyo Co Beta-amino-alpha- hydroxycarboxylic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
DE69322127D1 (de) 1998-12-24
EP0574135B1 (de) 1998-11-18
EP0574135A1 (de) 1993-12-15

Similar Documents

Publication Publication Date Title
DE59309939D1 (de) Verfahren zur Herstellung von Arenbisphosphinoxide
DE69322127D1 (de) Verfahren zur Herstellung von Peptidderivaten und ihrer Salze
DE59303220D1 (de) Verfahren zur Herstellung von 1-Fluorcyclopropyl-methyl-keton
DE69312604D1 (de) Verfahren zur Herstellung von Dipeptid-Körnchen
DE69314899T2 (de) Verfahren zur Herstellung von Polyaminoborazinen
DE69305828D1 (de) Verfahren zur Herstellung von 2-Iminothiazolin-Derivaten und Verfahren zur Herstellung ihrer Zwischenprodukte
DE69315297T2 (de) Verfahren zur Herstellung von Omega-Alkenylchlorsilanen
DE69207051D1 (de) Substituierte Acetoxyazetidinonderivate und Verfahren zur Herstellung von 4-Acyloxyazetidinonderivate
DE69325079D1 (de) Verfahren zur Herstellung von Triorganochlorsilane
DE69303057D1 (de) Verfahren zur Herstellung von 3-Cyano-6-hydroxypyridin
DE69324875D1 (de) Verfahren zur Herstellung von Tetrathiafulvalen-Derivaten und ihrer Vorläufer
DE69315317D1 (de) Verfahren zur Herstellung von beta-Cyanoalkylsilanen
DE69321661D1 (de) Verfahren zur Herstellung von Triorganomonohalogensilan
DE69318765T2 (de) Verfahren zur Herstellung von Hydridoorganooxysilanen
DE59405997D1 (de) Verfahren zur Herstellung von Hydroxyalkylaminonitrobenzol-Derivaten
DE59301861D1 (de) Verfahren zur Herstellung von 2-Aryl-ethan-sulfonsäuren
DE59306959D1 (de) Verfahren zur Herstellung von Difluor- und Chlorfluorbenzodioxolen
DE69305279D1 (de) Verfahren zur Herstellung von Dimethyltetralin
DE69308193D1 (de) Verfahren zur Herstellung von Alpha-L-Aspartyl-L-Phenylalanin
DE69319683D1 (de) Verfahren zur Herstellung von Thienothiopyran-Derivaten
DE68920493D1 (de) Verfahren zur Herstellung von Derivaten von 2'-Deoxy-beta-cytidin und Salze davon.
DE59304663D1 (de) Verfahren zur Herstellung von 4-Hydroxymethyltetrahydropyran
DE69322893D1 (de) Verfahren zur Herstellung von Epsilon-poly-L-Lysin
DE59305709D1 (de) Verfahren zur Herstellung von 1,4-Diaminoanthrachinon-2,3-disulfonsäure und 1,4-Diaminoanthrachinon-2,3-dinitril
DE59310105D1 (de) Verfahren zur Herstellung von 2-Amino-5-methyl-pyridin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee